INVO Fertility, Inc. filed an 8-K on July 1, 2025, about several amendments to a Securities Purchase Agreement from June 27, 2025, allowing an institutional investor to purchase up to $10 million in additional preferred shares, and subsequently executed agreements involving 1,800 preferred shares exchanged for $1.8 million in principal under a debenture. Additionally, on June 26, 2025, the investor acquired 500 preferred shares valued at $500,000, adjusting the conversion price to $0.95 per share.